sinecod for children
novartis consumer health s.a. - butamirate (butamirate citrate) - drops oral - 5mg/ml
sinecod
novartis consumer health s.a. - butamirate (butamirate citrate) - syrup - 1,5mg/ml
voltaren emulgel
novartis consumer health s.a. - diclofenac (diclofenac diethylamine) - gel for external use - 10mg/g
otrivin complete
gsk consumer healthcare, israel ltd - ipratropium bromide; xylometazoline hydrochloride - nasal spray, solution - ipratropium bromide 0.6 mg/ml; xylometazoline hydrochloride 0.5 mg/ml - ipratropium bromide - symptomatic treatment of nasal congestion and rhinorrhea in connection with common cold in adults.
cataflam
novartis consumer health australasia pty ltd (nz) - diclofenac potassium 25mg; ; - tablet - 25 mg - active: diclofenac potassium 25mg excipient: calcium phosphate colloidal silicon dioxide iron oxide red macrogol 8000 magnesium stearate maize starch microcrystalline cellulose opacode brown s-1-9210hv povidone purified talc sodium starch glycolate sucrose titanium dioxide
fenistil gel
novartis consumer health s.a. - dimetindene (dimetindene maleate) - gel - 1mg/g
fenistil new
novartis consumer health s.a. - dimetindene (dimetindene maleate) - drops oral (solution) - 1mg/ml
fenistil new drops oral (solution)
novartis consumer health s.a. - dimetindene (dimetindene maleate) - drops oral (solution) - 1mg/ml
amlodipine/valsartan/hct novartis 10/320/25 amlodipine/valsartan/hydrochlorothiazide tablet blister pack
novartis pharmaceuticals australia pty ltd - valsartan, quantity: 320 mg; hydrochlorothiazide, quantity: 25 mg; amlodipine besilate, quantity: 13.87 mg (equivalent: amlodipine, qty 10 mg) - tablet, film coated - excipient ingredients: magnesium stearate; colloidal anhydrous silica; crospovidone; microcrystalline cellulose; hypromellose; purified talc; iron oxide yellow; macrogol 4000 - amlodipine/valsartan/hct novartis is indicated only as substitution therapy for the treatment of hypertension in patients whose blood pressure is already adequately controlled on the triple combination of amlodipine, valsartan and hydrochlorothiazide taken either as three single component formulations or as dual-component formulation with a single component formulation, all components at the same dose level. treatment should not be initiated with these fixed-dose combinations (see dosage and administration).
amlodipine/valsartan/hct novartis 10/160/25 amlodipine/valsartan/hydrochlorothiazide tablet blister pack
novartis pharmaceuticals australia pty ltd - amlodipine besilate, quantity: 13.87 mg (equivalent: amlodipine, qty 10 mg); hydrochlorothiazide, quantity: 25 mg; valsartan, quantity: 160 mg - tablet, film coated - excipient ingredients: colloidal anhydrous silica; magnesium stearate; crospovidone; microcrystalline cellulose; hypromellose; purified talc; iron oxide yellow; macrogol 4000 - amlodipine/valsartan/hct novartis is indicated only as substitution therapy for the treatment of hypertension in patients whose blood pressure is already adequately controlled on the triple combination of amlodipine, valsartan and hydrochlorothiazide taken either as three single component formulations or as dual-component formulation with a single component formulation, all components at the same dose level. treatment should not be initiated with these fixed-dose combinations (see dosage and administration).